Navigation Links
Telome Health, Inc. Launches With Exclusive IP Portfolio
Date:3/22/2011

MENLO PARK, Calif., March 22, 2011 /PRNewswire/ -- Telome Health, Inc. (THI) officially launched today with an exclusive worldwide intellectual property portfolio. THI will provide telomere length data from tissue samples for academic research, pharmaceutical drug development, and health monitoring.

THI leverages the predictive power of data related to telomeres, the protective caps at the ends of chromosomes, to assess health status, disease and mortality risk, and responses to specific therapies. The test will provide doctors with important data about their patients' health and disease risk to better inform their clinical decisions. Telomere health measures integrate many factors, both genetic and non-genetic. "We recently secured an exclusive worldwide license to the telomere patent portfolio developed by Dr. Richard Cawthon at the University of Utah. In addition to clinical utility, measuring telomere length will also allow people to gauge their overall health status and determine whether lifestyle changes are necessary and potentially indicate the effectiveness of those changes," stated Daniel Hunt, THI's interim CEO.

Two of THI's founders played key roles in developing the field of telomere biology: Professor Elizabeth Blackburn, Ph.D. (UCSF), the 2009 Nobel Laureate in Physiology or Medicine, for her seminal work on telomere structure and function and the discovery of telomerase, the enzyme that synthesizes telomeric DNA; and Calvin Harley, Ph.D., who linked telomeres and telomerase to human cell aging and disease, and translated telomere science into drug development at Geron Corporation as VP Research and CSO.

"Two of the patents in the portfolio cover the qPCR method for measuring telomere length, which is scalable and cost-effective and we believe will be the dominant technology for high-throughput assays and a key competitive advantage for Telome Health in our field," explained Dr. Harley, THI's CSO. "Dr. Cawthon, an internationally known expert in the field, is a member of THI's Clinical and Scientific advisory board. As telomere biology continues to evolve, THI will develop and commercialize additional diagnostics based on telomere biology. We are now accepting requests to assay telomere length in samples from academic, pharmaceutical, and corporate research groups, with health monitoring testing planned for the second half of 2011."

"Telomeres are the only part of the genome itself that can be changed by lifestyle choices, and hence telomere length measurements can provide valuable feedback on ones' disease risks and, potentially, the effects of lifestyle changes," stated Dr. Blackburn, THI's Co-founder and Chair of the Scientific and Clinical Advisory Board. "Science and discovery are my personal passion and motivation. While laboratory research is my usual focus, the opportunity presented by THI is so compelling that I have been deeply committed to this concept since its first inception. The multiple applications toward prevention, wellness, and individualized treatment presented by telomere-based diagnostics can support a paradigm shift for healthcare worldwide. I am pleased to be associated with this natural extension of my research."

Background Information on Telomere Biology

Established Science: Over 4,000 peer-reviewed scientific publications relate to telomere biology and aging or disease. Many of these studies establish both associations and causal links between short telomeres or altered telomerase levels and major diseases, and demonstrate the diagnostic utility of these "telome measures" to monitor health status, disease risk, prognosis, and drug response.

A Broad-Spectrum Disease and Drug Response Biomarker: While most biomarkers are specific for certain diseases, telomere shortness uniquely is a parameter predictive of an increased risk of many diseases, including cancer, cardiovascular, fibrotic and inflammatory diseases, depression, and diabetes. In some studies, it is superior to conventional biomarkers.

In addition, telomere length is emerging as a measure that has utility in predicting drug response. Many patients have little or no response to certain drug therapies and many of these therapies have serious adverse effects. Recent data has suggested that telomere length may help predict responders, non-responders, or subjects who are at increased risk for negative side effects of certain drugs.

A "Health Biomarker:" There are over 180 million people in the US over age 30 – and a growing number of them have an interest in actively managing their health. THI founders believe that telomere length as an overall health barometer will be an integral component in the personalized medicine revolution, which includes individualized health maintenance plans based on new health monitoring tools.

www.telomehealth.com

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this press release regarding potential applications of THI's technology constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and protection of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements.

For more information, contact:

Maureen Smith, Executive Director, Strategic Communications
msmith@telomehealth.com


'/>"/>
SOURCE Telome Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti
2. NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, The Directors Common Fund to Provide Human Tissue for GTEx, the New Genotype-Tissue Expression Project
3. Anodyne Health, Seven Other Companies Join in Significant Expansion of MedAxiom Corporate Partner Program
4. Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers
5. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
6. FDA Places Politics Above Science, Womens Health, and Informed Consent
7. Seventh Annual Healthcare Unbound Conference Features Innovative Applications of Remote Monitoring, Home Telehealth, mHealth, Social Media and eHealth to Manage Diseases and Promote Wellness
8. North Carolina GlaxoSmithKline Foundation Working With Nonprofits to Promote Health, Science and Education Through Ribbon of Hope Grants
9. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
10. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
11. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... Dr. Vivek Ahuja , ... Ste phen Schmidt ... of cloud-based software solutions for life sciences, today announced key new ... wealth of insight to a growing business.  This will bolster the ... George Phillips joined ArisGlobal in the position of Vice President ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology:
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... Angeles, CA (PRWEB) , ... April 29, 2016 , ... ... Mirmelli, a mother and divorcee, shares her enthusiasm for Botox and lip injections, which ... the world famous youth oriented Coachella Valley Music and Arts Festival. The article explains ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, 2016 members of the ... signature of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. ... a 70% tax credit to individuals and corporations which donate directly to a “rural ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is ... its new location in the Exchange Furniture Mall at 112 Vilseck Road in Fort ... Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists Thomas ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... products, announces the Gyrociser, an exercise invention which aids in proper muscle development. ... Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened ...
Breaking Medicine News(10 mins):